MetabolicFDA Approved

Exenatide (Byetta/Bydureon)

Subcutaneous injection (twice daily or weekly extended-release)

Overview

A synthetic version of exendin-4, a 39-amino acid peptide originally isolated from the saliva of the Gila monster lizard (Heloderma suspectum). Exenatide shares 53% homology with human GLP-1 and is resistant to DPP-4 degradation.

Mechanism of Action

It activates GLP-1 receptors to enhance insulin secretion, suppress glucagon, slow gastric emptying, and promote beta-cell preservation..

Research Summary & Key Findings

First GLP-1 RA approved by the FDA (Byetta, 2005). Extended-release formulation (Bydureon) approved in 2012 for once-weekly dosing. Clinical trials demonstrated significant HbA1c reduction and modest weight loss. EXSCEL cardiovascular outcomes trial confirmed cardiovascular safety.

Clinical Status

FDA Approved

Exenatide (Byetta/Bydureon) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.

Administration Routes

Subcutaneous injection (twice daily or weekly extended-release)

Related Peptides in Metabolic

Semaglutide (Ozempic/Wegovy)

FDA Approved

A glucagon-like peptide-1 receptor agonist (GLP-1 RA) with 94% amino acid homology to native GLP-1. Semaglutide enhances...

View details

Tirzepatide (Mounjaro/Zepbound)

FDA Approved

A first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide activat...

View details

Retatrutide

In Clinical Trials

An investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The gluc...

View details

AOD-9604

Investigational

A modified 16-amino acid fragment (amino acids 176-191) of the C-terminus of human growth hormone with an added tyrosine...

View details

Find a Provider

Find a verified provider who offers Exenatide (Byetta/Bydureon) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Exenatide (Byetta/Bydureon).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.